248 related articles for article (PubMed ID: 28487624)
1. Clara Cell Protein Expression in Mechanically Ventilated Term and Preterm Infants with Respiratory Distress Syndrome and at Risk of Bronchopulmonary Dysplasia: A Pilot Study.
Guzmán-Bárcenas J; Calderón-Moore A; Baptista-González H; Irles C
Can Respir J; 2017; 2017():8074678. PubMed ID: 28487624
[TBL] [Abstract][Full Text] [Related]
2. Cord blood Clara cell protein CC16 predicts the development of bronchopulmonary dysplasia.
Schrama AJ; Bernard A; Poorthuis BJ; Zwinderman AH; Berger HM; Walther FJ
Eur J Pediatr; 2008 Nov; 167(11):1305-12. PubMed ID: 18521627
[TBL] [Abstract][Full Text] [Related]
3. Clara cell secretory protein (CC16) as a peripheral blood biomarker of lung injury in ventilated preterm neonates.
Sarafidis K; Stathopoulou T; Diamanti E; Soubasi V; Agakidis C; Balaska A; Drossou V
Eur J Pediatr; 2008 Nov; 167(11):1297-303. PubMed ID: 18521628
[TBL] [Abstract][Full Text] [Related]
4. Club cell secretory protein (CC16) in gastric fluid at birth and subsequent lung disease in preterm infants.
Hagman C; Björklund LJ; Hellgren G; Tufvesson E; Hansen-Pupp I
Pediatr Pulmonol; 2018 Oct; 53(10):1399-1406. PubMed ID: 29992757
[TBL] [Abstract][Full Text] [Related]
5. Disordered pathways of fibrin turnover in lung lavage of premature infants with respiratory distress syndrome.
Viscardi RM; Broderick K; Sun CC; Yale-Loehr AJ; Hessamfar A; Taciak V; Burke KC; Koenig KB; Idell S
Am Rev Respir Dis; 1992 Aug; 146(2):492-9. PubMed ID: 1489146
[TBL] [Abstract][Full Text] [Related]
6. Elevated type IV collagen in bronchoalveolar lavage fluid from infants with bronchopulmonary dysplasia.
Ohki Y; Kato M; Kimura H; Nako Y; Tokuyama K; Morikawa A
Biol Neonate; 2001 Jan; 79(1):34-8. PubMed ID: 11150828
[TBL] [Abstract][Full Text] [Related]
7. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease.
Hasan J; Beharry KD; Valencia AM; Strauss A; Modanlou HD
Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766
[TBL] [Abstract][Full Text] [Related]
8. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.
Ballabh P; Simm M; Kumari J; Califano C; Aghai Z; Laborada G; Sison C; Cunningham-Rundles S
Pediatr Pulmonol; 2003 May; 35(5):392-9. PubMed ID: 12687597
[TBL] [Abstract][Full Text] [Related]
9. Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia.
Munshi UK; Niu JO; Siddiq MM; Parton LA
Pediatr Pulmonol; 1997 Nov; 24(5):331-6. PubMed ID: 9407566
[TBL] [Abstract][Full Text] [Related]
10. Pepsin, a marker of gastric contents, is increased in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia.
Farhath S; He Z; Nakhla T; Saslow J; Soundar S; Camacho J; Stahl G; Shaffer S; Mehta DI; Aghai ZH
Pediatrics; 2008 Feb; 121(2):e253-9. PubMed ID: 18245400
[TBL] [Abstract][Full Text] [Related]
11. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
12. Endothelin 1 as a predictor marker for bronchopulmonary dysplasia in preterm neonates with respiratory distress syndrome.
El Shemi MS; Tawfik S; Khafagy SM; Hamza MT; Youssef AM
J Neonatal Perinatal Med; 2017; 10(1):79-83. PubMed ID: 28304322
[TBL] [Abstract][Full Text] [Related]
13. A comparison of KL-6 and Clara cell protein as markers for predicting bronchopulmonary dysplasia in preterm infants.
Wang K; Huang X; Lu H; Zhang Z
Dis Markers; 2014; 2014():736536. PubMed ID: 25242856
[TBL] [Abstract][Full Text] [Related]
14. Elevation of fibronectin levels in lung secretions of infants with respiratory distress syndrome and development of bronchopulmonary dysplasia.
Watts CL; Fanaroff AA; Bruce MC
J Pediatr; 1992 Apr; 120(4 Pt 1):614-20. PubMed ID: 1552403
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 balance in the lungs of preterm infants who develop bronchopulmonary dysplasia.
Kakkera DK; Siddiq MM; Parton LA
Biol Neonate; 2005; 87(2):82-90. PubMed ID: 15539764
[TBL] [Abstract][Full Text] [Related]
16. Value of serum and bronchoalveolar fluid lavage pro- and anti-inflammatory cytokine levels for predicting bronchopulmonary dysplasia in premature infants.
Köksal N; Kayik B; Çetinkaya M; Özkan H; Budak F; Kiliç Ş; Canitez Y; Oral B
Eur Cytokine Netw; 2012 Jun; 23(2):29-35. PubMed ID: 22591771
[TBL] [Abstract][Full Text] [Related]
17. Compare severity of bronchopulmonary dysplasia in neonates with respiratory distress syndrome treated with surfactant to without surfactant.
Chotigeat U; Ratchatanorravut S; Kanjanapattanakul W
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S35-40. PubMed ID: 22043752
[TBL] [Abstract][Full Text] [Related]
18. Association between Hemoglobin Levels in the First 3 Days of Life and Bronchopulmonary Dysplasia in Preterm Infants.
Duan J; Kong X; Li Q; Hua S; Zhang S; Feng Z; Zhang X
Am J Perinatol; 2016 Aug; 33(10):998-1002. PubMed ID: 27120476
[TBL] [Abstract][Full Text] [Related]
19. Increased activity of interleukin-6 but not tumor necrosis factor-alpha in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia.
Bagchi A; Viscardi RM; Taciak V; Ensor JE; McCrea KA; Hasday JD
Pediatr Res; 1994 Aug; 36(2):244-52. PubMed ID: 7970941
[TBL] [Abstract][Full Text] [Related]
20. Role of antioxidant nutrients and lipid peroxidation in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia.
Falciglia HS; Johnson JR; Sullivan J; Hall CF; Miller JD; Riechmann GC; Falciglia GA
Am J Perinatol; 2003 Feb; 20(2):97-107. PubMed ID: 12660915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
